Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Hyo Sup Shim Byoung Chul Cho Min Hee Hong Soonmyung Paik |
| Publication date | June 1, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |